top
Search terms
Results 1 - 7 of 7 - ordered by :
Eurointervention

The patients in the overweight group had more risk factors for cardiovascular disease; baseline characteristics included males (77.5% vs. 71.4%), smoking (51.2% vs. 43.6%), diabetes mellitus (49.9% ...

Date : 06/05/2016 Item size : 30865 bytes
Epeuropace

Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease Abstract Aims Atrial fibrillation (AF) and coronary artery ...

Europace, CLINICAL RESEARCH, Benjamin A. Steinberg, Samuel H. Broderick, Renato D. Lopes, Linda K. Shaw, Kevin L. Thomas, Tracy A. DeWald, James P. Daubert, Eric D. Peterson, Christopher B. Granger, ...

Date : 01/09/2014
Ehjournal

Allocation to rosuvastatin when compared with placebo was associated with a 27% reduction in the relative risk of developing AF during the trial period; specifically, AF was reported among 138 ...

European Heart Journal, Peña, Jessica M., MacFadyen, Jean, Glynn, Robert J., Ridker, Paul M

Date : 01/02/2012 Item size : 251353 bytes
Ehjournal

Abstract Aims The aim of this study was to determine whether angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-II receptor blocker (ARB) use is associated with lower rates of ...

European Heart Journal, Sorbets, Emmanuel, Labreuche, Julien, Simon, Tabassome, Delorme, Laurent, Danchin, Nicolas, Amarenco, Pierre, Goto, Shinya, Meune, Christophe, Eagle, Kim A., Bhatt, Deepak L., ...

Date : 07/07/2014 Item size : 344002 bytes
Ehjournal

Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history Introduction Coronary heart disease (CHD) is the leading cause of death in the ...

European Heart Journal, Tada, Hayato, Melander, Olle, Louie, Judy Z., Catanese, Joseph J., Rowland, Charles M., Devlin, James J., Kathiresan, Sekar, Shiffman, Dov

Date : 07/02/2016
Ehjournal

Allocation to rosuvastatin when compared with placebo was associated with a 27% reduction in the relative risk of developing AF during the trial period; specifically, AF was reported among 138 ...

European Heart Journal, Peña, Jessica M., MacFadyen, Jean, Glynn, Robert J., Ridker, Paul M

Date : 01/02/2012 Item size : 244442 bytes
Ehjournal

Abstract Aims The aim of this study was to determine whether angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-II receptor blocker (ARB) use is associated with lower rates of ...

European Heart Journal, Sorbets, Emmanuel, Labreuche, Julien, Simon, Tabassome, Delorme, Laurent, Danchin, Nicolas, Amarenco, Pierre, Goto, Shinya, Meune, Christophe, Eagle, Kim A., Bhatt, Deepak L., ...

Date : 07/07/2014